As the years passed, joblessness in the region increased. Two Ladakh outfits spearheading the statehood stir called off the ...

Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD: Munich, Germany Thursday, October 9, 2025, 11 ...

Objectives: This study aimed to evaluate the effectiveness of value-based care (VBC) interventions in slowing the progression of chronic kidney disease (CKD), as measured by changes in estimated ...

Imagine zooming into matter at the quantum scale, where tiny particles can interact in more than a trillion configurations at ...